Please ensure Javascript is enabled for purposes of website accessibility

Created by volunteers, for you. Consider donating or advertising on this website to fuel our mission.

How to target Glutamine as a Cancer Source with Dr. Thomas Seyfried, MD

Targeting Glutamine to Deprive Tumor Cells: Expert Insights by Dr. Thomas Seyfried

Video Overview & Chapters

00:07 Glutamine is essential for immune system and gut health.

  • Glutamine, which can be synthesized from glucose, is the most abundant amino acid in our bloodstream.
  • Glutamine plays a crucial role in the urea cycle and is considered important for overall immune system and gut function.

00:52 Glutamine can be targeted as a cancer source

  • Glutamine is essential for certain physiological systems, but there is no food that can deprive you of it
  • Water-only fasting with exercise can lower blood glutamine levels significantly, which may impact tumor cells

01:40 Targeting Glutamine to slow cancer cells progression.

  • Pulsing tumor cells with glutamine to degrade them gradually.
  • Long-term water fasting may help some people in cancer remission.

02:24 Body can use tumor cells as food during fasting

  • Body turns on tumor cells as a food source during fasting.
  • Tumor cells are inefficient consumers of energy.

03:04 Putting the body under restricted conditions can trigger the surveillance system to target and destroy tumor cells.

  • Restrictive conditions lead to tumor cell destruction and redistribution of fuel.
  • Stress, whether emotional or physical, can impact blood sugar levels and corticosteroids.

03:49 Targeting glutamine as a cancer source

  • Stress management is an important therapeutic strategy for cancer treatment, alongside dietary and drug-based methods targeting glutamine.
  • Emotional stress reduction is crucial for the body’s overall healing ability, in addition to fuel deprivation caused by diet and drugs targeting glutamine.

04:36 Targeting glucose is crucial for using a powerful cancer therapy drug.

  • Patients were given high dosages of the drug without targeting glucose, resulting in misuse and negative outcomes.
  • The drug should be a part of cancer therapy cocktails, but bureaucratic challenges hinder patient access.

05:13 Challenges in accessing potentially beneficial drugs for cancer patients

  • State and Federal paperwork hurdles can hinder access to drugs even for compassionate use
  • Financial incentives play a role in limiting availability of off-patent drugs with therapeutic potential